Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA)

Carregando...
Imagem de Miniatura
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
PEIX, Amalia
MESQUITA, Claudio Tinoco
PAEZ, Diana
PEREIRA, Carlos Cunha
FELIX, Renata
GUTIERREZ, Claudia
JAIMOVICH, Rodrigo
OLAYA, Pastor
Citação
NUCLEAR MEDICINE COMMUNICATIONS, v.35, n.8, p.818-823, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, I-123-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
Palavras-chave
coronary artery disease, dilated cardiomyopathy, gated myocardial perfusion SPECT, left ventricular dyssynchrony, MIBG, PET imaging, heart failure
Referências
  1. AlJaroudi W, 2012, J NUCL CARDIOL, V19, P958, DOI 10.1007/s12350-012-9592-z
  2. AlJaroudi W, 2011, J NUCL CARDIOL, V18, P36, DOI 10.1007/s12350-010-9296-1
  3. AlJaroudi WA, 2010, J NUCL CARDIOL, V17, P398, DOI 10.1007/s12350-009-9169-7
  4. American Heart Association, 2004, AM HEART ASS HEART S
  5. Bax JJ, 2005, J AM COLL CARDIOL, V46, P2153, DOI 10.1016/j.jacc.2005.09.019
  6. Bleeker GB, 2006, CIRCULATION, V113, P969, DOI 10.1161/CIRCULATIONAHA.105.543678
  7. Bocchi Edimar Alcides, 2013, Curr Cardiol Rev, V9, P147
  8. Boogers MJ, 2010, J AM COLL CARDIOL, V55, P2769, DOI 10.1016/j.jacc.2009.12.066
  9. Boogers MJ, 2011, EUR J NUCL MED MOL I, V38, P230, DOI 10.1007/s00259-010-1621-z
  10. Chen CC, 2012, EUR J NUCL MED MOL I, V39, P1904, DOI 10.1007/s00259-012-2208-7
  11. Chen J, 2008, J NUCL CARDIOL, V15, P127, DOI 10.1016/j.nuclcard.2007.11.004
  12. Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474
  13. Chen J, 2011, J NUCL CARDIOL, V18, P685, DOI 10.1007/s12350-011-9392-x
  14. Chen Ji, 2012, J Nucl Cardiol, V19, P92, DOI 10.1007/s12350-011-9438-0
  15. Cubillos-Garzon LA, 2004, AM HEART J, V147, P412, DOI 10.1016/j.ahj.2003.07.026
  16. Donal E, 2008, EUROPACE, V10, P70, DOI 10.1093/europace/eun229
  17. Einstein AJ, 2012, J AM COLL CARDIOL, V59, P553, DOI 10.1016/j.jacc.2011.08.079
  18. Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b
  19. Fauchier L, 2002, J AM COLL CARDIOL, V40, P2022, DOI 10.1016/S0735-1097(02)02569-X
  20. Flotats A, 2010, EUR J NUCL MED MOL I, V37, P1802, DOI 10.1007/s00259-010-1491-4
  21. Germano G, 2006, NUCL MED, P609
  22. Godoy IE, 1998, J AM COLL CARDIOL, V31, P1598, DOI 10.1016/S0735-1097(98)00144-2
  23. Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001
  24. Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013
  25. Henneman MM, 2007, J NUCL MED, V48, P1104, DOI 10.2967/jnumed.107.039925
  26. HO KKL, 1993, CIRCULATION, V88, P107
  27. Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f
  28. Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
  29. ICRP, 2008, ANN ICRP, V38, P159
  30. International Atomic Energy Agency (IAEA), 2012, IAEA HUM HLTH SER, V23 STI/PUB/1566
  31. Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014
  32. Kerwin WF, 2000, J AM COLL CARDIOL, V35, P1221, DOI 10.1016/S0735-1097(00)00555-6
  33. Khan FZ, 2012, J AM COLL CARDIOL, V59, P1509, DOI 10.1016/j.jacc.2011.12.030
  34. Khatibzadeh S, 2013, INT J CARDIOL, V168, P1186, DOI 10.1016/j.ijcard.2012.11.065
  35. Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071
  36. Leclercq C, 2002, J AM COLL CARDIOL, V39, P194, DOI 10.1016/S0735-1097(01)01747-8
  37. Ludwig DR, 2012, J NUCL MED, V53, P1892, DOI 10.2967/jnumed.112.106344
  38. McAlister FA, 2007, EVID REP TECHNOL ASS, V152, P1
  39. Najafi F, 2009, EUR J HEART FAIL, V11, P472, DOI 10.1093/eurjhf/hfp029
  40. Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056
  41. Suffoletto MS, 2006, CIRCULATION, V113, P960, DOI 10.1161/CIRCULATIONAHA.105.571455
  42. Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204
  43. Tanaka H, 2010, EUR HEART J, V31, P1690, DOI 10.1093/eurheartj/ehq213
  44. Toussaint JF, 2003, PACE, V26, P1815, DOI 10.1046/j.1460-9592.2003.t01-1-00275.x
  45. Travin MI, 2013, J NUCL CARDIOL, V20, P128, DOI 10.1007/s12350-012-9655-1
  46. Verberne HJ, 2008, EUR HEART J, V29, P1147, DOI 10.1093/eurheartj/ehn113